Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;26(12):1050-1059.
doi: 10.1016/j.cardfail.2020.07.010. Epub 2020 Aug 1.

Metabolomic Profile in HFpEF vs HFrEF Patients

Camilla Hage  1 , Lars Löfgren  2 , Filippos Michopoulos  3 , Ralph Nilsson  2 , Pia Davidsson  2 , Chanchal Kumar  2 , Mattias Ekström  4 , Maria J Eriksson  5 , Patrik Lyngå  6 , Bengt Persson  7 , Hakan Wallén  4 , Li Ming Gan  8 , Hans Persson  4 , Cecilia Linde  9
Affiliations

Metabolomic Profile in HFpEF vs HFrEF Patients

Camilla Hage et al. J Card Fail. 2020 Dec.

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are associated with metabolic derangements, which may have different pathophysiological implications.

Methods and results: In new-onset HFpEF (EF of ≥50%, n = 46) and HFrEF (EF of <40%, n = 75) patients, 109 endogenous plasma metabolites including amino acids, phospholipids and acylcarnitines were assessed using targeted metabolomics. Differentially altered metabolites and associations with clinical characteristics were explored. Patients with HFpEF were older, more often female with hypertension, atrial fibrillation, and diabetes compared with patients with HFrEF. Patients with HFpEF displayed higher levels of hydroxyproline and symmetric dimethyl arginine, alanine, cystine, and kynurenine reflecting fibrosis, inflammation and oxidative stress. Serine, cGMP, cAMP, l-carnitine, lysophophatidylcholine (18:2), lactate, and arginine were lower compared with patients with HFrEF. In patients with HFpEF with diabetes, kynurenine was higher (P = .014) and arginine lower (P = .014) vs patients with no diabetes, but did not differ with diabetes status in HFrEF. Decreasing kynurenine was associated with higher eGFR only in HFpEF (Pinteraction = .020).

Conclusions: Patients with new-onset HFpEF compared with patients with new-onset HFrEF display a different metabolic profile associated with comorbidities, such as diabetes and kidney dysfunction. HFpEF is associated with indices of increased inflammation and oxidative stress, impaired lipid metabolism, increased collagen synthesis, and downregulated nitric oxide signaling. Together, these findings suggest a more predominant systemic microvascular endothelial dysfunction and inflammation linked to increased fibrosis in HFpEF compared with HFrEF.

Clinical trial registration: ClinicalTrials.gov NCT03671122 https://clinicaltrials.gov.

Keywords: HFpEF; Metabolomics; inflammation; microvascular dysfunction; pathophysiology.

PubMed Disclaimer

Associated data